Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 2
2014 2
2015 3
2017 1
2018 1
2019 3
2020 3
2021 1
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; FIGARO-DKD Investigators. Pitt B, et al. N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449181 Clinical Trial.
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Dec 1;45(12):2991-2998. doi: 10.2337/dc22-0294. Diabetes Care. 2022. PMID: 35972218 Free PMC article. Clinical Trial.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.
Prediction Accuracy of Mechanism-Based Oral Absorption Model for Dogs.
Akiyama Y, Kimoto T, Mukumoto H, Miyake S, Ito S, Taniguchi T, Nomura Y, Matsumura N, Fujita T, Sugano K. Akiyama Y, et al. Among authors: matsumura n. J Pharm Sci. 2019 Aug;108(8):2728-2736. doi: 10.1016/j.xphs.2019.03.015. Epub 2019 Mar 21. J Pharm Sci. 2019. PMID: 30905705
Prediction of Oral Drug Absorption in Rats from In Vitro Data.
Akiyama Y, Matsumura N, Ono A, Hayashi S, Funaki S, Tamura N, Kimoto T, Jiko M, Haruna Y, Sarashina A, Ishida M, Nishiyama K, Fushimi M, Kojima Y, Fujita T, Sugano K. Akiyama Y, et al. Among authors: matsumura n. Pharm Res. 2023 Feb;40(2):359-373. doi: 10.1007/s11095-022-03173-6. Epub 2022 Feb 15. Pharm Res. 2023. PMID: 35169960
Prediction Characteristics of Oral Absorption Simulation Software Evaluated Using Structurally Diverse Low-Solubility Drugs.
Matsumura N, Hayashi S, Akiyama Y, Ono A, Funaki S, Tamura N, Kimoto T, Jiko M, Haruna Y, Sarashina A, Ishida M, Nishiyama K, Fushimi M, Kojima Y, Yoneda K, Nakanishi M, Kim S, Fujita T, Sugano K. Matsumura N, et al. J Pharm Sci. 2020 Mar;109(3):1403-1416. doi: 10.1016/j.xphs.2019.12.009. Epub 2019 Dec 18. J Pharm Sci. 2020. PMID: 31863733
A new CysLT1 and CysLT2 receptors-mediated anaphylaxis guinea pig model.
Sekioka T, Kadode M, Osakada N, Fujita M, Matsumura N, Yamaura Y, Nakade S, Nabe T, Kawabata K. Sekioka T, et al. Among authors: matsumura n. Prostaglandins Leukot Essent Fatty Acids. 2017 Apr;119:18-24. doi: 10.1016/j.plefa.2017.03.002. Epub 2017 Mar 8. Prostaglandins Leukot Essent Fatty Acids. 2017. PMID: 28410666
ONO-8430506: A Novel Autotaxin Inhibitor That Enhances the Antitumor Effect of Paclitaxel in a Breast Cancer Model.
Iwaki Y, Ohhata A, Nakatani S, Hisaichi K, Okabe Y, Hiramatsu A, Watanabe T, Yamamoto S, Nishiyama T, Kobayashi J, Hirooka Y, Moriguchi H, Maeda T, Katoh M, Komichi Y, Ota H, Matsumura N, Okada M, Sugiyama T, Saga H, Imagawa A. Iwaki Y, et al. Among authors: matsumura n. ACS Med Chem Lett. 2020 May 14;11(6):1335-1341. doi: 10.1021/acsmedchemlett.0c00200. eCollection 2020 Jun 11. ACS Med Chem Lett. 2020. PMID: 32551021 Free PMC article.
Harmonizing solubility measurement to lower inter-laboratory variance - progress of consortium of biopharmaceutical tools (CoBiTo) in Japan.
Ono A, Matsumura N, Kimoto T, Akiyama Y, Funaki S, Tamura N, Hayashi S, Kojima Y, Fushimi M, Sudaki H, Aihara R, Haruna Y, Jiko M, Iwasaki M, Fujita T, Sugano K. Ono A, et al. Among authors: matsumura n. ADMET DMPK. 2019 Aug 5;7(3):183-195. doi: 10.5599/admet.704. eCollection 2019. ADMET DMPK. 2019. PMID: 35350659 Free PMC article.
20 results